Special Issue "Nanocrystals"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (15 March 2016)
Prof. Dr. Arvind K. Bansal
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, SAS Nagar (Mohali), Punjab 160 062, India
Website | E-Mail
Phone: +91-0172-2214 682 (Ext. 2126)
Interests: pre-formulation profiling; solid state characterization; polymorphism; amorphous systems; particle engineering; nano-crystalline dispersions; enhancement of oral bioavailability
Studies related to pharmaceutical nanocrystal started in the beginning of 1990’s and first product entered the market after 10 years of intensive research. Today, the number of marketed products is increasing all the time. Products for different drug delivery routes and various categories of dosage forms like oral solids and liquids have been marketed. The first applications nanocrystals were for improved solubility, and this is still the most well-known property of nanocrystal formulations. However, novel applications like controlled release formulations are also being studied. Accordingly, nanocrystals can be said to be very versatile option for drug delivery purposes.
This Special Issue on nanocrystals will include a variety of research articles, both reviews and original research contributions, dealing with drug nanocrystals. This special issue of Pharmaceutics, aims to provide an overview of well established nanocrystal technologies, marketed products and emerging areas for application of nanocrystals. We invite manuscripts dealing with topics related to development, manufacturing, quality and in vivo fate of nanocrystals.
Dr. Leena Peltonen
Dr. Arvind Bansal
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- controlled release